Cardiovascular Pharmacogenetics /
This volume intends to provide a panorama of our current understanding of the role of genetic information in the management of cardiovascular disease. A recurring plea from the contributors is the need for more hypothesis-driven, rigorously conducted and analysed clinical research. Perhaps this comp...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
2004.
|
| Series: | Handbook of experimental pharmacology ;
160. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Preface
- The Role of Genotyping in Pharmacological Therapy
- Pharmacogenetics and the Treatment of Cardiovascular Disease
- Genetic Polymorphisms and Cardiovascular Drug Metabolism
- Genes that Modify Susceptibility to Atherosclerosis: Targets for Drug Action
- Lipid Lowering Responses Modified by Genetic Variation
- The Genetic Basis of Essential Hypertension and its Implications for Treatment
- Genetic Predisposition to Cardiac Hypertrophy
- Genetic Determinants of Susceptibility, Prognosis and Treatment in Heart Failure
- The Genetics of Cardiac Channelopathies: Implications for Therapeutics
- Insulin Resistance and Cardiovascular Disease
- New Insights From Genetics
- Genetic Disruption of Nitric Oxide Synthases and Cardiovascular Disease
- Lessons from a Candidate Gene
- Association of Thrombotic Disease with Genetic Polymorphism of Haemostatic Genes
- Relevance to Pharmacogenetics
- Genetic Polymorphisms of Adhesion Molecules
- Genetic Regulation of Metalloproteinase Activity: Pathogenic and Therapeutic Implications
- Current Perspectives on Gene and Cell-based Therapies for Myocardial Protection, Rescue and Repair.